Cargando…

Lipid-Based Drug Delivery Systems for Diseases Managements

Liposomes are tiny lipid-based vesicles composed of one or more lipid bilayers, which facilitate the encapsulation of hydrophilic, lipophilic, and amphiphilic biological active agents. The description of the physicochemical properties, formulation methods, characteristics, mechanisms of action, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gbian, Douweh Leyla, Omri, Abdelwahab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495957/
https://www.ncbi.nlm.nih.gov/pubmed/36140237
http://dx.doi.org/10.3390/biomedicines10092137
_version_ 1784794150097387520
author Gbian, Douweh Leyla
Omri, Abdelwahab
author_facet Gbian, Douweh Leyla
Omri, Abdelwahab
author_sort Gbian, Douweh Leyla
collection PubMed
description Liposomes are tiny lipid-based vesicles composed of one or more lipid bilayers, which facilitate the encapsulation of hydrophilic, lipophilic, and amphiphilic biological active agents. The description of the physicochemical properties, formulation methods, characteristics, mechanisms of action, and large-scale manufacturing of liposomes as delivery systems are deeply discussed. The benefits, toxicity, and limitations of the use of liposomes in pharmacotherapeutics including in diagnostics, brain targeting, eye and cancer diseases, and in infections are provided. The experimental approaches that may reduce, or even bypass, the use of liposomal drug drawbacks is described. The application of liposomes in the treatment of numerous diseases is discussed.
format Online
Article
Text
id pubmed-9495957
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94959572022-09-23 Lipid-Based Drug Delivery Systems for Diseases Managements Gbian, Douweh Leyla Omri, Abdelwahab Biomedicines Review Liposomes are tiny lipid-based vesicles composed of one or more lipid bilayers, which facilitate the encapsulation of hydrophilic, lipophilic, and amphiphilic biological active agents. The description of the physicochemical properties, formulation methods, characteristics, mechanisms of action, and large-scale manufacturing of liposomes as delivery systems are deeply discussed. The benefits, toxicity, and limitations of the use of liposomes in pharmacotherapeutics including in diagnostics, brain targeting, eye and cancer diseases, and in infections are provided. The experimental approaches that may reduce, or even bypass, the use of liposomal drug drawbacks is described. The application of liposomes in the treatment of numerous diseases is discussed. MDPI 2022-08-31 /pmc/articles/PMC9495957/ /pubmed/36140237 http://dx.doi.org/10.3390/biomedicines10092137 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gbian, Douweh Leyla
Omri, Abdelwahab
Lipid-Based Drug Delivery Systems for Diseases Managements
title Lipid-Based Drug Delivery Systems for Diseases Managements
title_full Lipid-Based Drug Delivery Systems for Diseases Managements
title_fullStr Lipid-Based Drug Delivery Systems for Diseases Managements
title_full_unstemmed Lipid-Based Drug Delivery Systems for Diseases Managements
title_short Lipid-Based Drug Delivery Systems for Diseases Managements
title_sort lipid-based drug delivery systems for diseases managements
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495957/
https://www.ncbi.nlm.nih.gov/pubmed/36140237
http://dx.doi.org/10.3390/biomedicines10092137
work_keys_str_mv AT gbiandouwehleyla lipidbaseddrugdeliverysystemsfordiseasesmanagements
AT omriabdelwahab lipidbaseddrugdeliverysystemsfordiseasesmanagements